Cargando…

Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen

Background: According to current data, an effective Ebola virus vaccine should induce both humoral and T-cell immunity. In this work, we focused our efforts on methods for delivering artificial T-cell immunogen in the form of a DNA vaccine, using generation 4 polyamidoamine dendrimers (PAMAM G4) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karpenko, Larisa I., Apartsin, Evgeny K., Dudko, Sergei G., Starostina, Ekaterina V., Kaplina, Olga N., Antonets, Denis V., Volosnikova, Ekaterina A., Zaitsev, Boris N., Bakulina, Anastasiya Yu., Venyaminova, Aliya G., Ilyichev, Alexander A., Bazhan, Sergei I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760684/ https://www.ncbi.nlm.nih.gov/pubmed/33271964 http://dx.doi.org/10.3390/vaccines8040718

Ejemplares similares

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
por: Bazhan, Sergei I., et al.
Publicado: (2019)

Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice
por: Bazhan, Sergei, et al.
Publicado: (2020)

Design and Evaluation of Optimized Artificial HIV-1 Poly-T Cell-Epitope Immunogens
por: Reguzova, Alena, et al.
Publicado: (2015)

Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy
por: Karpenko, Larisa I., et al.
Publicado: (2017)

Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV‐1 polyepitope CTL immunogen
por: Karpenko, Larisa I., et al.
Publicado: (2012)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
por: Karpenko, Larisa I., et al.
Publicado: (2021)

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
por: Rudometov, Andrey P., et al.
Publicado: (2019)

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
por: Starostina, Ekaterina V., et al.
Publicado: (2021)

SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023)

PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens
por: Antonets, Denis V, et al.
Publicado: (2013)

Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01
por: Chikaev, Anton N., et al.
Publicado: (2015)

The Structural and Immunological Properties of Chimeric Proteins Containing HIV-1 MPER Sites
por: Rudometov, A. P., et al.
Publicado: (2019)

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
por: Shcherbakov, D. N., et al.
Publicado: (2015)

P19-36. Preclinical study of CombiHIVvac vaccine
por: Kaplina, O, et al.
Publicado: (2009)

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023)

P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins
por: Ilyichev, A, et al.
Publicado: (2009)

Dendrimer-Mediated Delivery of DNA and RNA Vaccines
por: Kisakova, Lyubov A., et al.
Publicado: (2023)

Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2021)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Dendriplex-Impregnated Hydrogels With Programmed Release Rate
por: Apartsin, Evgeny, et al.
Publicado: (2022)

Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Borgoyakova, M. B., et al.
Publicado: (2021)

Recent Advances in Nucleic Acid Targeting Probes and Supramolecular Constructs Based on Pyrene-Modified Oligonucleotides
por: Krasheninina, Olga A., et al.
Publicado: (2017)

Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
por: Knauer, Nadezhda, et al.
Publicado: (2019)

Effects of Cationic Dendrimers and Their Complexes with microRNAs on Immunocompetent Cells
por: Knauer, Nadezhda, et al.
Publicado: (2022)

P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1
por: Antonets, D, et al.
Publicado: (2009)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family
por: Antonets, Denis V, et al.
Publicado: (2010)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
por: Ilyichev, A.A., et al.
Publicado: (2020)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification
por: Mamoshina, Polina, et al.
Publicado: (2018)

Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model
por: Nizolenko, Lily Ph., et al.
Publicado: (2016)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
por: Rudometova, N.B., et al.
Publicado: (2022)

Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol
por: Kisakov, Denis Nikolaevich, et al.
Publicado: (2022)

P19-13. Recombinant proteins carrying peptide mimics of HIV-1
por: Chikaev, A, et al.
Publicado: (2009)

Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2023)

Hydrogels of Polycationic Acetohydrazone-Modified Phosphorus Dendrimers for Biomedical Applications: Gelation Studies and Nucleic Acid Loading
por: Apartsin, Evgeny K., et al.
Publicado: (2018)

Electrostatic Map of the SARS-CoV-2 Virion Specifies Binding Sites of the Antiviral Cationic Photosensitizer
por: Fedorov, Vladimir, et al.
Publicado: (2022)

Highly Stable Docetaxel-Loaded Nanoparticles Based on Poly(D,L-lactide)-b-Poly(ethylene glycol) for Cancer Treatment: Preparation, Characterization, and In Vitro Cytotoxicity Studies
por: Kuznetsova, Ekaterina V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dlpi81n9592eri4od1v81lhraj